錢江摩托(000913.SZ):與哈雷簽訂第一次補充協議 以約定就一款500cc排量目標摩托車的開發、生產和推出事宜
格隆匯 9 月 28日丨錢江摩托(000913.SZ)公佈,公司於2019年6月19日與Harley-Davidson Motor Company Group, LLC (“哈雷”或“H-D”)簽署了《Harley-Davidson Motor Company Group, LLC和浙江錢江摩托股份有限公司之間的長期合作協議》。
2020年9月28日,公司與哈雷就長期合作協議中推出第二款目標摩托車的計劃及其他一些事項達成了約定,簽訂了《長期合作協議第一次補充協議》,以約定就一款500cc排量目標摩托車的開發、生產和推出事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.